This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Wall Street is fixating on the recent biotech pullback, but the semiconductor sector saw even steeper declines, which worries one strategist.

03/26/15 - 12:57 PM EDT

'Don't Panic' Over Biotech Pullback, Especially After Last Week's Rally, Says Strategist

This week's biotech pullback was largely a matter of giving up gains from last week's Federal Reserve rally.

03/26/15 - 12:14 PM EDT

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Wall Street is fixating on the recent biotech pullback, but the semiconductor sector saw even steeper declines, which worries one strategist.

03/26/15 - 12:57 PM EDT

'Don't Panic' Over Biotech Pullback, Especially After Last Week's Rally, Says Strategist

'Don't Panic' Over Biotech Pullback, Especially After Last Week's Rally, Says Strategist

This week's biotech pullback was largely a matter of giving up gains from last week's Federal Reserve rally.

03/26/15 - 12:14 PM EDT

ZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-Off

ZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-Off

Biotech stocks are once again lower after leading Wednesday's market sell-off as investors jump out of the sector as fast as they can.

03/26/15 - 11:39 AM EDT

Here's an 'Attractive Entry Point' for Investors to Get Back Into Stocks

Here's an 'Attractive Entry Point' for Investors to Get Back Into Stocks

This week's biotech-led selloff in stocks is paving the way for buying opportunities down the road, one strategist says. A key indicator is the S&P 500, currently around 2,051.

03/26/15 - 10:55 AM EDT

Celgene (CELG) Stock Declines Today as Bubble Fears Grow

Celgene (CELG) Stock Declines Today as Bubble Fears Grow

  • Tickers in this article:
  • CELG

Celgene (CELG) shares are down as the company was caught up in today's biotech selloff that saw the index drop by 3% in trading today.

03/25/15 - 04:35 PM EDT

Dow Drops Three-Days in a Row, Chevron & Exxon Only Blue Chip Gainers

Dow Drops Three-Days in a Row, Chevron & Exxon Only Blue Chip Gainers

U.S. stocks fell for the third straight session at Wednesday's closing bell.

03/25/15 - 04:39 PM EDT

Kofax Jumps 46% on Lexmark Deal, Tesla Slides on Downgrade

Kofax Jumps 46% on Lexmark Deal, Tesla Slides on Downgrade

Major U.S. benchmarks are all trading narrowly lower as both the dollar and latest economic data weight on traders.

03/25/15 - 11:49 AM EDT

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

In April, Celladon is expecting results from a mid-stage study of a gene therapy aiming to improve the pumping ability of the heart in patients with advanced heart failure.

03/25/15 - 10:06 AM EDT

Jim Cramer -- 19 Companies That Could Get Acquired in 2015

Jim Cramer -- 19 Companies That Could Get Acquired in 2015

2015 is turning into an epic year for deals. Owning the stock of a likely takeover candidate can result in tidy profits. Jim Cramer names 19 companies to watch.

03/23/15 - 12:35 PM EDT

PTC Therapeutics CEO Liquidates Stock Ownership in His Own Company

PTC Therapeutics CEO Liquidates Stock Ownership in His Own Company

  • Tickers in this article:
  • PTCT

Biotech CEOs are supposed to be cheerleaders for their stock, so it's noteworthy when a CEO's pocketbook indicates otherwise.

03/24/15 - 10:39 AM EDT

Sonova CEO: Demographics Favorable, Swiss Franc Strength Painful

Sonova CEO: Demographics Favorable, Swiss Franc Strength Painful

The hearing aid sector has huge potential because only 20% of those who could benefit use them, said Lukas Braunschweiler, CEO of Sonova.

03/24/15 - 10:11 AM EDT

High Alert for Signs of Biotech Collapse Makes for Nervous Investors

High Alert for Signs of Biotech Collapse Makes for Nervous Investors

Biotech stocks may or may not be in a bubble, but investors are definitely worried about sky-high valuations.

03/24/15 - 08:56 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,686.50 -32.04 -0.18%
S&P 500 2,057.86 -3.19 -0.15%
NASDAQ 4,865.28 -11.2390 -0.23%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs